ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2017

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. AMZN
10. META

Go back to ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2017

JPMorgan Upgrades ResMed (RMD) to Overweight

January 24, 2017 7:56 AM EST

JPMorgan upgraded ResMed (NYSE: RMD) from Neutral to Overweight with a price target of $72.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

Shares of ResMed closed at $63.60 yesterday.

... More